Mohamed Moussaoui
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 28, 2026
In Silico Development of Novel Quinazoline-Based EGFR Inhibitors via 3D-QSAR, Docking, ADMET, and Molecular Dynamics.Mohamed Moussaoui, Soukayna Baammi, Mouna Baassi
|Dec 31, 2025
Structure-Guided Design of Novel Diarylpyrimidine-Based NNRTIs Through a Comprehensive In Silico Approach: 3D-QSAR, ADMET Evaluation, Molecular Docking, and Molecular Dynamics.Mouna Baassi, Mohamed Moussaoui, Sanchaita Rajkhowa
|Jun 17, 2025
Multitarget inhibition of CDK2, EGFR, and tubulin by phenylindole derivatives: Insights from 3D-QSAR, molecular docking, and dynamics for cancer therapy.Khadijah M Al-Zaydi, Soukayna Baammi, Mohamed Moussaoui
|Nov 25, 2024
Design and Optimization of Quinazoline Derivatives as Potent EGFR Inhibitors for Lung Cancer Treatment: A Comprehensive QSAR, ADMET, and Molecular Modeling Investigation.Mohamed Moussaoui, Soukayna Baammi, Hatim Soufi
|Jul 24, 2023
Multi-combined QSAR, molecular docking, molecular dynamics simulation, and ADMET of Flavonoid derivatives as potent cholinesterase inhibitors.Hatim Soufi, Mohamed Moussaoui, Soukayna Baammi
|May 19, 2023
In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies.Mohamed Moussaoui, Mouna Baassi, Soukayna Baammi
Pageof 1
